LinkedIn (original) (raw)

LinkedIn

This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://ir.spyre.com/2024-11-12-Spyre-Therapeutics-Announces-Positive-Interim-Results-from-Phase-1-Healthy-Volunteer-Trial-for-SPY001,-Its-Novel-Half-Life-Extended-anti-4-7-Antibody-for-the-Treatment-of-Inflammatory-Bowel-Disease,-with-a-Half-Life-of-90-Days-Supporting-the-Po

This experience is optimized for Chrome, Edge, and Safari